IBDEI056 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6574,0)
 ;;=J0713^^54^534^4^^^^1
 ;;^UTILITY(U,$J,358.3,6574,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6574,1,2,0)
 ;;=2^J0713
 ;;^UTILITY(U,$J,358.3,6574,1,3,0)
 ;;=3^CEFTAZIDIME INJ PER 500 MG
 ;;^UTILITY(U,$J,358.3,6575,0)
 ;;=J0735^^54^534^5^^^^1
 ;;^UTILITY(U,$J,358.3,6575,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6575,1,2,0)
 ;;=2^J0735
 ;;^UTILITY(U,$J,358.3,6575,1,3,0)
 ;;=3^CLONIDINE HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,6576,0)
 ;;=J1200^^54^534^7^^^^1
 ;;^UTILITY(U,$J,358.3,6576,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6576,1,2,0)
 ;;=2^J1200
 ;;^UTILITY(U,$J,358.3,6576,1,3,0)
 ;;=3^DIPHENHYDRAMINE HCL PER 50 MG
 ;;^UTILITY(U,$J,358.3,6577,0)
 ;;=J1270^^54^534^8^^^^1
 ;;^UTILITY(U,$J,358.3,6577,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6577,1,2,0)
 ;;=2^J1270
 ;;^UTILITY(U,$J,358.3,6577,1,3,0)
 ;;=3^DOXERCALCIFEROL INJ PER 1 MCG
 ;;^UTILITY(U,$J,358.3,6578,0)
 ;;=J1580^^54^534^10^^^^1
 ;;^UTILITY(U,$J,358.3,6578,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6578,1,2,0)
 ;;=2^J1580
 ;;^UTILITY(U,$J,358.3,6578,1,3,0)
 ;;=3^GARAMYCIN GENTAMICIN PER 80 MG
 ;;^UTILITY(U,$J,358.3,6579,0)
 ;;=J1642^^54^534^12^^^^1
 ;;^UTILITY(U,$J,358.3,6579,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6579,1,2,0)
 ;;=2^J1642
 ;;^UTILITY(U,$J,358.3,6579,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 10 U
 ;;^UTILITY(U,$J,358.3,6580,0)
 ;;=J1644^^54^534^13^^^^1
 ;;^UTILITY(U,$J,358.3,6580,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6580,1,2,0)
 ;;=2^J1644
 ;;^UTILITY(U,$J,358.3,6580,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 1000 U
 ;;^UTILITY(U,$J,358.3,6581,0)
 ;;=J2060^^54^534^14^^^^1
 ;;^UTILITY(U,$J,358.3,6581,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6581,1,2,0)
 ;;=2^J2060
 ;;^UTILITY(U,$J,358.3,6581,1,3,0)
 ;;=3^LORAZEPAM INJ PER 2 MG
 ;;^UTILITY(U,$J,358.3,6582,0)
 ;;=J2405^^54^534^15^^^^1
 ;;^UTILITY(U,$J,358.3,6582,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6582,1,2,0)
 ;;=2^J2405
 ;;^UTILITY(U,$J,358.3,6582,1,3,0)
 ;;=3^ONDANSETRON HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,6583,0)
 ;;=J2997^^54^534^2^^^^1
 ;;^UTILITY(U,$J,358.3,6583,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6583,1,2,0)
 ;;=2^J2997
 ;;^UTILITY(U,$J,358.3,6583,1,3,0)
 ;;=3^ALTEPLASE RECOMBINANT PER 1 MG
 ;;^UTILITY(U,$J,358.3,6584,0)
 ;;=J3260^^54^534^20^^^^1
 ;;^UTILITY(U,$J,358.3,6584,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6584,1,2,0)
 ;;=2^J3260
 ;;^UTILITY(U,$J,358.3,6584,1,3,0)
 ;;=3^TOBRAMYCIN SULFATE PER 80 MG
 ;;^UTILITY(U,$J,358.3,6585,0)
 ;;=J7682^^54^534^19^^^^1
 ;;^UTILITY(U,$J,358.3,6585,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6585,1,2,0)
 ;;=2^J7682
 ;;^UTILITY(U,$J,358.3,6585,1,3,0)
 ;;=3^TOBRAMYCIN NON-COM UNIT 300 MG
 ;;^UTILITY(U,$J,358.3,6586,0)
 ;;=P9047^^54^534^1^^^^1
 ;;^UTILITY(U,$J,358.3,6586,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6586,1,2,0)
 ;;=2^P9047
 ;;^UTILITY(U,$J,358.3,6586,1,3,0)
 ;;=3^ALBUMIN (HUMAN), 25%, 50ML
 ;;^UTILITY(U,$J,358.3,6587,0)
 ;;=J0886^^54^534^9^^^^1
 ;;^UTILITY(U,$J,358.3,6587,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6587,1,2,0)
 ;;=2^J0886
 ;;^UTILITY(U,$J,358.3,6587,1,3,0)
 ;;=3^EPOETIN ALFA 1000 UNITS ESRD
 ;;^UTILITY(U,$J,358.3,6588,0)
 ;;=J3370^^54^534^21^^^^1
 ;;^UTILITY(U,$J,358.3,6588,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6588,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,6588,1,3,0)
 ;;=3^VANCOMYCIN HCL 500 MG
 ;;^UTILITY(U,$J,358.3,6589,0)
 ;;=J0636^^54^534^3^^^^1
 ;;^UTILITY(U,$J,358.3,6589,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6589,1,2,0)
 ;;=2^J0636
 ;;^UTILITY(U,$J,358.3,6589,1,3,0)
 ;;=3^CALCITRIOL INJ PER 0.1 MCG
 ;;^UTILITY(U,$J,358.3,6590,0)
 ;;=J0882^^54^534^6^^^^1
 ;;^UTILITY(U,$J,358.3,6590,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6590,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,6590,1,3,0)
 ;;=3^DARBEPOETIN ALFA,ESRD USE 1MCG
 ;;^UTILITY(U,$J,358.3,6591,0)
 ;;=93000^^54^535^2^^^^1
 ;;^UTILITY(U,$J,358.3,6591,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6591,1,2,0)
 ;;=2^93000
 ;;^UTILITY(U,$J,358.3,6591,1,3,0)
 ;;=3^ELECTROCARDIOGRAM COMPLETE
 ;;^UTILITY(U,$J,358.3,6592,0)
 ;;=93784^^54^535^1^^^^1
 ;;^UTILITY(U,$J,358.3,6592,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6592,1,2,0)
 ;;=2^93784
 ;;^UTILITY(U,$J,358.3,6592,1,3,0)
 ;;=3^AMBULATORY BP MONITORING
 ;;^UTILITY(U,$J,358.3,6593,0)
 ;;=2010F^^54^535^4^^^^1
 ;;^UTILITY(U,$J,358.3,6593,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6593,1,2,0)
 ;;=2^2010F
 ;;^UTILITY(U,$J,358.3,6593,1,3,0)
 ;;=3^VITAL SIGNS RECORDED
 ;;^UTILITY(U,$J,358.3,6594,0)
 ;;=2001F^^54^535^5^^^^1
 ;;^UTILITY(U,$J,358.3,6594,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6594,1,2,0)
 ;;=2^2001F
 ;;^UTILITY(U,$J,358.3,6594,1,3,0)
 ;;=3^WEIGHT RECORD
 ;;^UTILITY(U,$J,358.3,6595,0)
 ;;=94760^^54^535^3^^^^1
 ;;^UTILITY(U,$J,358.3,6595,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6595,1,2,0)
 ;;=2^94760
 ;;^UTILITY(U,$J,358.3,6595,1,3,0)
 ;;=3^MEASURE BLOOD OXYGEN LEVEL
 ;;^UTILITY(U,$J,358.3,6596,0)
 ;;=0507F^^54^536^1^^^^1
 ;;^UTILITY(U,$J,358.3,6596,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6596,1,2,0)
 ;;=2^0507F
 ;;^UTILITY(U,$J,358.3,6596,1,3,0)
 ;;=3^PERITON DIALYSIS PLAN DOCD
 ;;^UTILITY(U,$J,358.3,6597,0)
 ;;=P9058^^54^536^2^^^^1
 ;;^UTILITY(U,$J,358.3,6597,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6597,1,2,0)
 ;;=2^P9058
 ;;^UTILITY(U,$J,358.3,6597,1,3,0)
 ;;=3^RBC, L/R, CMV-NEG, IRRAD
 ;;^UTILITY(U,$J,358.3,6598,0)
 ;;=S9445^^54^537^1^^^^1
 ;;^UTILITY(U,$J,358.3,6598,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6598,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,6598,1,3,0)
 ;;=3^PT EDUCATION INDIVID NOC
 ;;^UTILITY(U,$J,358.3,6599,0)
 ;;=99071^^54^537^2^^^^1
 ;;^UTILITY(U,$J,358.3,6599,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6599,1,2,0)
 ;;=2^99071
 ;;^UTILITY(U,$J,358.3,6599,1,3,0)
 ;;=3^PATIENT EDUCATION MATERIALS
 ;;^UTILITY(U,$J,358.3,6600,0)
 ;;=0505F^^54^538^1^^^^1
 ;;^UTILITY(U,$J,358.3,6600,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6600,1,2,0)
 ;;=2^0505F
 ;;^UTILITY(U,$J,358.3,6600,1,3,0)
 ;;=3^HEMODIALYSIS PLAN DOCD
 ;;^UTILITY(U,$J,358.3,6601,0)
 ;;=B4164^^54^539^7^^^^1
 ;;^UTILITY(U,$J,358.3,6601,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6601,1,2,0)
 ;;=2^B4164
 ;;^UTILITY(U,$J,358.3,6601,1,3,0)
 ;;=3^ENTERAL FORMULA, CAT IV
 ;;^UTILITY(U,$J,358.3,6602,0)
 ;;=A4730^^54^539^8^^^^1
 ;;^UTILITY(U,$J,358.3,6602,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6602,1,2,0)
 ;;=2^A4730
 ;;^UTILITY(U,$J,358.3,6602,1,3,0)
 ;;=3^FISTULA CANNULATION SET, EA
 ;;^UTILITY(U,$J,358.3,6603,0)
 ;;=B5000^^54^539^10^^^^1
 ;;^UTILITY(U,$J,358.3,6603,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6603,1,2,0)
 ;;=2^B5000
 ;;^UTILITY(U,$J,358.3,6603,1,3,0)
 ;;=3^PARENT NUT SOL,ANY STRTH,RENAL
 ;;^UTILITY(U,$J,358.3,6604,0)
 ;;=A4714^^54^539^12^^^^1
 ;;^UTILITY(U,$J,358.3,6604,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6604,1,2,0)
 ;;=2^A4714
 ;;^UTILITY(U,$J,358.3,6604,1,3,0)
 ;;=3^TREATED WATER PER GALLON
 ;;^UTILITY(U,$J,358.3,6605,0)
 ;;=C1752^^54^539^5^^^^1
 ;;^UTILITY(U,$J,358.3,6605,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6605,1,2,0)
 ;;=2^C1752
 ;;^UTILITY(U,$J,358.3,6605,1,3,0)
 ;;=3^CATH,HEMODIALYSIS,SHORT-TERM
 ;;^UTILITY(U,$J,358.3,6606,0)
 ;;=C1750^^54^539^4^^^^1
 ;;^UTILITY(U,$J,358.3,6606,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6606,1,2,0)
 ;;=2^C1750
 ;;^UTILITY(U,$J,358.3,6606,1,3,0)
 ;;=3^CATH, HEMODIALYSIS,LONG-TERM
 ;;^UTILITY(U,$J,358.3,6607,0)
 ;;=85302^^54^539^3^^^^1
 ;;^UTILITY(U,$J,358.3,6607,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6607,1,2,0)
 ;;=2^85302
 ;;^UTILITY(U,$J,358.3,6607,1,3,0)
 ;;=3^BLOOD CLOT INHIBITOR ANTIGEN
 ;;^UTILITY(U,$J,358.3,6608,0)
 ;;=99070^^54^539^2^^^^1
 ;;^UTILITY(U,$J,358.3,6608,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6608,1,2,0)
 ;;=2^99070
 ;;^UTILITY(U,$J,358.3,6608,1,3,0)
 ;;=3^AV FISTULA KIT
 ;;^UTILITY(U,$J,358.3,6609,0)
 ;;=A9900^^54^539^11^^^^1
 ;;^UTILITY(U,$J,358.3,6609,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6609,1,2,0)
 ;;=2^A9900
 ;;^UTILITY(U,$J,358.3,6609,1,3,0)
 ;;=3^SUPPLY/ACCESSORY/SERVICE
 ;;^UTILITY(U,$J,358.3,6610,0)
 ;;=A4690^^54^539^6^^^^1
 ;;^UTILITY(U,$J,358.3,6610,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6610,1,2,0)
 ;;=2^A4690
 ;;^UTILITY(U,$J,358.3,6610,1,3,0)
 ;;=3^DIALYZER, EACH
 ;;^UTILITY(U,$J,358.3,6611,0)
 ;;=A4750^^54^539^1^^^^1
 ;;^UTILITY(U,$J,358.3,6611,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6611,1,2,0)
 ;;=2^A4750
 ;;^UTILITY(U,$J,358.3,6611,1,3,0)
 ;;=3^ART OR VENOUS BLOOD TUBING
 ;;^UTILITY(U,$J,358.3,6612,0)
 ;;=E1590^^54^539^9^^^^1
 ;;^UTILITY(U,$J,358.3,6612,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6612,1,2,0)
 ;;=2^E1590
 ;;^UTILITY(U,$J,358.3,6612,1,3,0)
 ;;=3^HEMODIALYSIS MACHINE
 ;;^UTILITY(U,$J,358.3,6613,0)
 ;;=90371^^54^540^3^^^^1
 ;;^UTILITY(U,$J,358.3,6613,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6613,1,2,0)
 ;;=2^90371
 ;;^UTILITY(U,$J,358.3,6613,1,3,0)
 ;;=3^HEP B IG IM
 ;;^UTILITY(U,$J,358.3,6614,0)
 ;;=90740^^54^540^4^^^^1
 ;;^UTILITY(U,$J,358.3,6614,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6614,1,2,0)
 ;;=2^90740
 ;;^UTILITY(U,$J,358.3,6614,1,3,0)
 ;;=3^HEPB VACC ILL PAT 3 DOSE IM
 ;;^UTILITY(U,$J,358.3,6615,0)
 ;;=90632^^54^540^2^^^^1
 ;;^UTILITY(U,$J,358.3,6615,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6615,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,6615,1,3,0)
 ;;=3^HEP A VACCINE ADULT IM
 ;;^UTILITY(U,$J,358.3,6616,0)
 ;;=90703^^54^540^8^^^^1
 ;;^UTILITY(U,$J,358.3,6616,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6616,1,2,0)
 ;;=2^90703
 ;;^UTILITY(U,$J,358.3,6616,1,3,0)
 ;;=3^TETANUS VACCINE IM
 ;;^UTILITY(U,$J,358.3,6617,0)
 ;;=90732^^54^540^5^^^^1
 ;;^UTILITY(U,$J,358.3,6617,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6617,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,6617,1,3,0)
 ;;=3^PNEUMOCOCCAL VACCINE
 ;;^UTILITY(U,$J,358.3,6618,0)
 ;;=86580^^54^540^6^^^^1
 ;;^UTILITY(U,$J,358.3,6618,1,0)
 ;;=^358.31IA^3^2
